Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.28 USD | +1.18% | -2.28% | +27.76% |
04-15 | Applied Therapeutics, Inc. Announces Management Changes | CI |
03-28 | Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review | DJ |
Business Summary
Number of employees: 25
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 0 | nan % | 10 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 10 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 45 | 19/01/16 | |
Les Funtleyder
DFI | Director of Finance/CFO | 55 | 31/05/16 |
Chief Operating Officer | 57 | 12-27 | |
Chief Tech/Sci/R&D Officer | 64 | 31/07/18 | |
Catherine Thorpe
AUD | Comptroller/Controller/Auditor | - | 15/06/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Skyler
BRD | Director/Board Member | 77 | 31/03/19 |
Joel Marcus
BRD | Director/Board Member | 76 | 31/12/16 |
Teena Lerner
BRD | Director/Board Member | 66 | 28/02/17 |
Stacy J. Kanter
BRD | Director/Board Member | 65 | 30/04/19 |
Les Funtleyder
DFI | Director of Finance/CFO | 55 | 31/05/16 |
Chief Executive Officer | 45 | 19/01/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 114,241,803 | 106,635,318 ( 93.34 %) | 0 | 93.34 % |
Company contact information
Applied Therapeutics, Inc.
545 5th Avenue Suite 1400
10017, New York
+212 220 9226
http://www.appliedtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.76% | 489M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- APLT Stock
- Company Applied Therapeutics, Inc.